SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-325674
Filing Date
2018-11-14
Accepted
2018-11-13 17:35:35
Documents
1
Group Members
ALAN FRAZIERFHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.FHM VI, L.L.C.FHM VI, L.P.FRAZIER HEALTHCARE VI, L.P.JAMES N. TOPPERNADER NAININATHAN EVERYPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A (AMENDMENT NO. 1) d653598dsc13da.htm SC 13D/A 206898
  Complete submission text file 0001193125-18-325674.txt   208847
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89009 | Film No.: 181179389
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A